Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $35.4100 (-3.91%) ($35.1100 - $35.4100) on Thu. Nov. 18, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.02% (three month average) | RSI | 39 | Latest Price | $35.4100(-3.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.6% a day on average for past five trading days. | Weekly Trend | HALO declines -2.6% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(49%) IWM(48%) IWC(45%) IWN(45%) | Factors Impacting HALO price | HALO will decline at least -1.01% in a week (0% probabilities). VIXM(-29%) VXX(-10%) UUP(-10%) GLD(-3%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.01% (StdDev 2.02%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $31.99(-9.66%) | Resistance Level | $38.54 | 5 Day Moving Average | $37.53(-5.65%) | 10 Day Moving Average | $38.22(-7.35%) | 20 Day Moving Average | $38.54(-8.12%) | To recent high | -17.5% | To recent low | 0% | Market Cap | $4.84b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |